Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022
Promissory notes payable, net of debt discount	$ 22,211		$ 22,211				$ 27,437
Derivative liability	1,398,982		1,398,982				1,317
SBA Loan - non current	115,008		115,008				114,700
Convertible note payable - noncurrent, net	15,735		15,735				175,720
Promissory notes payable - concurrent	82,957		82,957				16,649
Additional paid in capital	1,498,332		1,498,332				1,364,007
Total stockholders’ deficit	(3,529,464)	$ (1,780,195)	(3,529,464)	$ (1,780,195)	$ (3,095,617)	$ (2,669,788)	(1,954,359)	$ (1,623,100)	$ (1,803,721)	$ (1,099,222)
Gain (loss) on change in fair value of derivative liability	163,586	47,725	(345,832)	44,529
Amortization debt discount	(127,477)	(30,576)	(289,528)	(72,551)
Amortization of deferred financing costs	(43,456)		(43,456)
Interest expense	(414,588)	(50,036)	(647,399)	(131,133)
Interest expense - related parties	(1,897)	(1,896)	(6,375)	(2,522)
Net loss	(518,847)	$ (157,095)	(1,710,105)	(697,482)
Net loss per share of common stock:
Accumulated deficit	(5,021,001)		(5,021,001)				$ (3,310,896)
Adjustments to reconcile net income to cash used in operating activities:
Gain (loss) on change in fair value of derivative liability			345,832	(44,529)
Amortization debt discount			289,528	72,551
Financing fee			43,456
Changes in operating assets and liabilities
Accounts payable and accrued liabilities			176,925	237,376
Net cash used in operating activities			(830,047)	(366,356)
Cash flows from financing activities:
Proceeds from convertible notes payable and notes payable			941,675	297,482
Net cash provided by financing activities			905,115	342,902
Non-cash investing and financing transactions:
Common stock in connection with promissory note			120,000	1,509
Recognition of derivative liability as debt discount			200,750	48,428
Deferred offering costs in connection with promissory note			449,999
Amortization of deferred offering costs to debt discount			43,456
Previously Reported [Member]
Deferred financing costs, net	445,684		445,684
Total assets	725,722		725,722
Accounts payable and accrued liabilities	947,284		947,284
Promissory notes payable, net of debt discount	12,835		12,835
Convertible notes payable, net of debt discount	1,426,836		1,426,836
Derivative liability	1,387,303		1,387,303
Total current liabilities	4,124,720		4,124,720
SBA Loan - non current	114,700		114,700
Promissory notes payable - concurrent	120,112		120,112
Total liabilities	4,359,532		4,359,532
Additional paid in capital	1,405,174		1,405,174
Total stockholders’ deficit	(3,633,810)		(3,633,810)
Gain (loss) on change in fair value of derivative liability	238,379		(271,039)
Amortization debt discount	(134,346)		(296,397)
Amortization of deferred financing costs
Interest expense	505,676		707,693
Interest expense - related parties	2,149		6,627
Net loss	$ (529,649)		$ (1,721,293)
Net loss per share of common stock:
Basic and diluted			$ (0.02)
Accumulated deficit	$ (5,032,189)		$ (5,032,189)
Adjustments to reconcile net income to cash used in operating activities:
Gain (loss) on change in fair value of derivative liability			(271,039)
Amortization debt discount			296,397
Financing fee			484,197
Changes in operating assets and liabilities
Accounts payable and accrued liabilities			282,577
Net cash used in operating activities			(362,766)
Cash flows from financing activities:
Proceeds from convertible notes payable and notes payable			659,804
Repayment of promissory notes payable			(87,121)
Net cash provided by financing activities			437,834
Non-cash investing and financing transactions:
Common stock in connection with promissory note			26,842
Recognition of derivative liability as debt discount			200,750
Deferred offering costs in connection with promissory note			477,500
Amortization of deferred offering costs to debt discount			31,816
Revision of Prior Period, Adjustment [Member]
Deferred financing costs, net	(39,141)		(39,141)
Total assets	(39,141)		(39,141)
Accounts payable and accrued liabilities	(105,652)		(105,652)
Promissory notes payable, net of debt discount	(12,835)		(12,835)
Convertible notes payable, net of debt discount	(40,208)		(40,208)
Derivative liability	11,679		11,679
Total current liabilities	(122,375)		(122,375)
SBA Loan - non current	308		308
Promissory notes payable - concurrent	(37,155)		(37,155)
Total liabilities	(143,487)		(143,487)
Additional paid in capital	93,158		93,158
Total stockholders’ deficit	104,346		104,346
Gain (loss) on change in fair value of derivative liability	(74,793)		(74,793)
Amortization debt discount	6,869		6,869
Amortization of deferred financing costs	(43,456)		(43,456)
Interest expense	(91,088)		(60,294)
Interest expense - related parties	(252)		(252)
Net loss	$ 10,802		$ 11,188
Net loss per share of common stock:
Basic and diluted
Accumulated deficit	$ 11,188		$ 11,188
Adjustments to reconcile net income to cash used in operating activities:
Gain (loss) on change in fair value of derivative liability			616,871
Amortization debt discount			(6,869)
Amortization of deferred financing costs
Financing fee			(440,741)
Changes in operating assets and liabilities
Accounts payable and accrued liabilities			(105,652)
Net cash used in operating activities			(447,768)
Cash flows from financing activities:
Proceeds from convertible notes payable and notes payable			281,871
Repayment of promissory notes payable			35,561
Net cash provided by financing activities			467,281
Non-cash investing and financing transactions:
Common stock in connection with promissory note			93,158
Recognition of derivative liability as debt discount			(200,750)
Deferred offering costs in connection with promissory note			(27,501)
Amortization of deferred offering costs to debt discount			11,640
As Restated [Member]
Deferred financing costs, net	406,543		406,543
Total assets	686,581		686,581
Accounts payable and accrued liabilities	841,632		841,632
Promissory notes payable, net of debt discount
Convertible notes payable, net of debt discount	1,386,628		1,386,628
Derivative liability	1,398,682		1,398,682
Total current liabilities	4,002,345		4,002,345
SBA Loan - non current	115,008		115,008
Convertible note payable - noncurrent, net	15,735		15,735
Promissory notes payable - concurrent	82,957		82,957
Total liabilities	4,216,045		4,216,045
Additional paid in capital	1,498,332		1,498,332
Total stockholders’ deficit	(3,529,464)		(3,529,464)
Gain (loss) on change in fair value of derivative liability	163,586		(345,832)
Amortization debt discount	(127,477)		(289,528)
Amortization of deferred financing costs	(43,456)		(43,456)
Interest expense	4,145,880		647,399
Interest expense - related parties	1,897		6,375
Net loss	$ (518,847)		$ (1,710,105)
Net loss per share of common stock:
Basic and diluted			$ (0.02)
Accumulated deficit	$ (5,021,001)		$ (5,021,001)
Adjustments to reconcile net income to cash used in operating activities:
Gain (loss) on change in fair value of derivative liability			345,832
Amortization debt discount			289,528
Financing fee			43,456
Changes in operating assets and liabilities
Accounts payable and accrued liabilities			176,925
Net cash used in operating activities			(830,047)
Cash flows from financing activities:
Proceeds from convertible notes payable and notes payable			941,675
Repayment of promissory notes payable			(51,560)
Net cash provided by financing activities			905,115
Non-cash investing and financing transactions:
Common stock in connection with promissory note			120,000
Recognition of derivative liability as debt discount
Deferred offering costs in connection with promissory note			449,999
Amortization of deferred offering costs to debt discount			$ 43,456

Driveitaway Holdings, Inc. 10-Q/A